NONTUBERCULOUS MYCOBACTERIA - CURRENT RISK IN BULGARIA
DOI:
https://doi.org/10.58395/gnmhxb78Keywords:
Nontuberculous Mycobacteria, geographical diversity, LPAAbstract
Background: Nontuberculous mycobacteria (NTM) are generally free-living and have a potential to cause opportunistic infection. More than 190 species of NTM have been identified (http://www.bacterio.net/mycobacterium.html), up to 60 species of them are pathogenic. The distribution is geographically specific for some species and others are cosmopolitan. Understanding their diversity has practical value for the treatment and management of NTM disease. Except for isolated reports, there is no accurate information about NTM spread among Bulgarian patients.
Material and Methods: We retrospectively analysed the data on the NTM isolated from patients throughout the country for the period from January 2010 to December 2017. Identification to the species level was done by Line Probe Assay (LPA).
Results: 586 NTM strains were identified. We calculated the rate of NTM isolation in Bulgaria and NTM disease incidence by applying microbiological criteria defined by the American Thoracic Society (ATS). As a result, the laboratory isolation rate amounted to 1/100 000 people for the period, and when applying only the ATS criteria, the prevalence of NTM disease was 0,23 per 100 000 people. In both cases, we reported that NTM disease incidence remains low as compared to tuberculosis, though with an increasing trend. The prevalence of NTM varied significantly between northern and southern Bulgaria, as well as between the capital and the rest of the country's regions.
Conclusions: Slow growing NTM species predominate in Bulgaria but rapidly growing ones have isolation levels higher than the average for Europe and closer to that of Asian countries. Given the demographic situation in Bulgaria and the changing climatic factors, NTM infections need special attention.
Downloads
References
ECDS. Tuberculosis Surveillance and Monitoring in Europe. Available online: https://www.ecdc.europa.eu/en/publicationsdata/tuberculosis-surveillance-and-monitoring-europe-2022-2020-data (accessed on 20 March 2022).
Bachiyska E, Atanasova Y, Baykova A, Yordanova S, Todorova Y. First Etiologically Confirmed Cases of Mycobacterium marinum Infection in Bulgaria. Folia Medica 2020; 62(2): 398-402. https://doi.org/10.3897/folmed.62.e47220
Tsankova G, Kaludova V, Todorova T, Ermenlieva N, Georgieva E. Nontuberculous tuberculosis caused by Mycobacterium gordonae - clinical case report. J of IMAB. 2015; Jul-Sep 21(3):856-858. http://dx.doi.org/10.5272/jimab.2015213.856
ECDC HIV/AIDS surveillance in Europe 2020, 2019 data PDF ISBN 978-92-9498-527-9 https://doi.org/10.2900/073965 TQ-02-20-965-EN-N
Wallace R. J. Jr, Iakhiaeva E., Williams M. D., Brown-Elliott B. A., Vasireddy S., Vasireddy R., Lande L., Peterson D. D., Sawicki J., Kwait R., et al. Absence of Mycobacterium intracellulare and presence of Mycobacterium chimaera in household water and biofilm samples of patients in the United States with Mycobacterium avium complex respiratory disease. J Clin Microbiol. 2013; 51:1747–1752. https://doi.org/10.1128/JCM.00186-13
Hoefsloot W., J. van Ingen Andrejak C, Angeby K, Bauriaud R, Bemer P et all. Nontuberculous Mycobacteria Network European Trials Group. A NTM-NET collaborative study. The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study ERJ Express. 2013; Dec;42(6):1604-13. https://doi.org/10.1183/09031936.00149212
Kim, J., Seong, M. W., Kim, E. C., Han, S. K., & Yim, . J. Frequency and clinical implications of the isolation of rare nontuberculous mycobacteria. BMC infectious diseases, 2015; 9. https://doi.org/10.1186/s12879-014-0741-7
Falkinham J. O. 3rd. Surrounded by Mycobacteria: nontuberculous mycobacteria in the human environment. J Appl Microbiol. 2009; 107(2):356-367. https://doi.org/10.1111/j.1365-2672.2009.04161.x
Malcolm K. C., Caceres S. M., Honda J. R., Davidson R. M., Epperson L. E., Strong M., et al. Mycobacterium abscessus displays fitness for fomite transmission. Appl. Environ. Microbiol. 2017; 83:e00562-17. https://doi.org/10.1128/AEM.00562-17
Цанкова Г. С. Възможни асоциации между заболяемостта от туберкулоза във Варненски регион и ефекта от приложената BCG ваксина; Дис. труд 2013г. МУ Варна. ProQuest Number: 10648501
van der Werf M. J., Ködmön C., Katalinić-Janković V., Kummik T., Soini H., Richter, E., Papaventsis D., Tortoli E, Perrin M., van Soolingen D., Zolnir-Dovč M., Ostergaard, Thomsen V. Inventory study of non-tuberculous mycobacteria in the European Union. BMC Infect Dis. 2014; Feb 6;14:62. https://doi.org/10.1186/1471-2334-14-62
van Ingen J. Diagnosis of nontuberculous mycobacteria., Semin Respir Crit Care Med 2013; 34:103-109. https://doi.org/10.1055/s-0033-1333569
Fattorini L., A. Iacobino, F. Giannoni. SMI-NTM, Pilot Study on nontuberculous mycobacteria infections in Italy, European Journal of Public Health, 2020; September, Volume 30, Issue Supplement 5. https://doi.org/10.1093/eurpub/ckaa166.843
Chen C. Y., Chen H. Y., Chou C. H., et al. Pulmonary infection caused by nontuberculous mycobacteria in a medical center in Taiwan, 2005–2008. Diagn Microbiol Infect Dis 2012; 72: 47–51. https://doi.org/10.1016/j.diagmicrobio.2011.09.009
Simons S., van Ingen J., Hsueh P. R., Van Hung N., Dekhuijzen P.N., Boeree M.J. et al. Nontuberculous mycobacteria in respiratory tract infections, eastern Asia. Emerg Infect Dis. 2011; 17: 343–349. https://doi.org/10.3201/eid1703.100604
Richards, C. J., and Olivier, K. N. Nontuberculous mycobacteria in cystic fibrosis. Semin. Respir. Crit. Care Med. 2019; 40, 737–750. https://doi.org/10.1055/s-0039-1693706
van der Werf M. J., Ködmön C., Katalinić-Janković V., Kummik T., Soini H., Richter E., Papaventsis D., Tortoli E, Perrin M., van Soolingen D., Zolnir-Dovč M., Ostergaard Thomsen V. Inventory study of non-tuberculous mycobacteria in the European Union. 2014, BMC Infect Dis. 2014; Feb 6;14:62. https://doi.org/10.1186/1471-2334-14-62
Dicker R, Coronado F, Koo D, Parrish RG. Principles of epidemiology in public health practice; an introduction to applied epidemiology and biostatistics. 3rd ed; Corporate Authors(s): Centers for Disease Control and Prevention (U.S.), Epidemiology Program Office; Centers for Disease Control and Prevention (U.S.), Office of Workforce and Career Development.;2006; URL: https://stacks.cdc.gov/view/cdc/6914 https://doi.org/10.1164/rccm.200604-571ST
Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, et al. ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007 Feb 15;175(4):367-416. https://doi.org/10.1164/rccm.200604-571ST
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Yuliana Atanasova, Stanislava Yordanova, Ana Baykova, Assoc. prof. Elizabeta Bachiyska, MD, PhD (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
